Detailed entry information

Protein Information (annotations from UniProt)

Database IDHIV0000541
UniProt IDQ01151
Primary gene name(s)CD83
Synonym gene name(s)unknown
Protein nameCD83 antigen
Protein functionMay play a significant role in antigen presentation or the cellular interactions that follow lymphocyte activation.
Subcellular locationMembrane;
Single-pass type I membrane protein.
ECO codeClick here for more information.
Amino acid sequence
FASTA format: Q01151
Gene Ontology
(Biological Process)
Complete annatation
defense response [GO:0006952];
humoral immune response [GO:0006959];
negative regulation of interleukin-4 production [GO:0032713];
positive regulation of CD4-positive, alpha-beta T cell differentiation [GO:0043372];
positive regulation of interleukin-10 production [GO:0032733];
positive regulation of interleukin-2 production [GO:0032743];
regulation of cytokine production [GO:0001817];
response to organic cyclic compound [GO:0014070];
signal transduction [GO:0007165]
Gene Ontology
(Molecular Function)
Complete annatation
Gene Ontology
(Cellular Component)
Complete annatation
external side of plasma membrane [GO:0009897];
integral component of plasma membrane [GO:0005887];
plasma membrane [GO:0005886]
Protein-protein interaction114721
Phylogenetic treeQ01151
HIV replication factor status Zhou et al., Cell. Host. Microbe., 2008
Brass et al., Science, 2008
Smith et al., J. Immunol, 2010
gene status
Lu et al., J. Virol., 2011
      Folds changes 8h: unknown; Folds changes 16h: unknown; Tested: unknown;
Schoggins JW and Rice CM, Curr. Opin. Virol., 2011
      Targeted viruses: unknown
      Viral life cycle: unknown
      Mechanism related to antiviral activity: unknown
Anti-viral restriction factor Liu et al., Retrovirology, 2011
      unknown (Triplicates)

Gene Expression Profile       top

            Up-regulated;            Down-regulated

For brief introduction to each study, please go to the help page.

Gene expression during HIV latency

(1). Mohammadi et al., PLoS Pathog., 2014

Differentially expressed transcripts (Pairwise) during latency and subsequent viral reactivation using several agents - Primary CD4+ T-cell based model

DMSO: Dimethyl suloxyde (negative control) - 0.0033% final
SAHA: Vorinostat (Histone deacetylase inhibitor) - 0.5 μM
CD3: TCR Stimulation by IL-2+ antiCD3/anti-CD28 antibodies
IL7: Interleukin-7 based stimulation
DISU: Disulfiram (alcohol dehydrogenase inhibitor) - 0.5 μM
AZA: 5-azacytidine (AZA; DNA methylation inhibitor) - 1 μM
Experimental Condition Log2 Fold Change P value Adjusted P value
AZA vs. CD36.6967258623032200
AZA vs. DISU0.1651719440851830.5608569373946770.950460102163903
AZA vs. IL70.2417120010196780.2666915173289390.999311006273513
AZA vs. SAHA0.8751329989968340.0008405990678425070.0185251320886812
DISU vs. CD3-6.545618894241400
DISU vs. IL70.06376103449886450.8329320867630250.964820397354322
DISU vs. SAHA0.7118898180359360.02001393847091460.162893121258893
DMSO vs. AZA-0.01287129517456960.9484857597678591
DMSO vs. CD3-6.7212292734549100
DMSO vs. DISU-0.1811072128968620.5187672275035410.914196078390533
DMSO vs. IL70.2601514011856350.2033112214630970.713933534487816
DMSO vs. SAHA0.8825619429526430.0004735109890278140.0103377098573794
HIV vs. Mock in Activation0.4569367636060730.4638633133550090.999983755607037
HIV vs. Mock in Latency0.02891552693834320.8754096272343570.999834320637052
IL7 vs. CD3-6.4513463217945300
SAHA vs. CD3-5.8454672100331100
SAHA vs. IL70.6325643038375510.01459346945139030.0814144924168235
(2). Iglesias-Ussel et al., J. Virol., 2013

Up and Downregulated transcripts during Latency (Latently infected CD4+ T cells vs Uninfected)- Primary CD4+Tcell based model
Log2 Fold Change P Value
unknown unknown

Gene expression during HIV infection and replication

(1). Imbeault et al., PloS Pathog., 2012

Transcriptomic profiling of HIV-1 infected CD4+ T cells - Primary CD4+ T cells
Experiment type Log2 Fold Change P Value Adjusted P Value
Infected vs. Mock unknown unknown unknown
Infected vs. Bystander unknown unknown unknown
(2). Lefebvre et al., J. Virol., 2011

Transcriptome analysis of T-cell line (Sup T1)
Log2 Fold Change unknown
(3). Li et al., J. Immunol., 2013

Lymphatic tissue
Acute Fold Change Acute P Value Asymt Fold Change Asypt P Value AIDS Fold Change AIDS P Value
unknown unknown unknown unknown unknown unknown
(4). Chang et al., MBio., 2011

Transcriptome analysis of T-cell line (Sup T1)

Derived from Sherrill-Mix et al., BMC Retrovirol., 2015 cross validation
Up-regulated (True) FALSE
(5). Sherrill-Mix et al., BMC Retrovirol., 2015

Deep RNA-seq analysis of primary human T cell infected with low passage HIV isolate HIV89.6 - Primary CD4+ T cell based
Test Status Log2 Fold Change P Value
OK 0.712623 0.000305467
(6). Rotger et al., PLoS Pathog., 2010

Genome-wide mRNA expression of CD4+ T cells from HIV-infected patient
(Genes differentially expressed (at adjusted p<0.01) according to the empirical Bayes approach)
Log2 Fold Change P Value
unknown unknown

Proteomic/Transcriptomics studies indicating differentially expressed genes mediated by HIV

(1). Greenwood et al., Elife, 2016

Activated (CD3/CD28) Primary human CD4+ T cells infected with pNL4-3-dE-EGFP. The table shows the complete (unfiltered) TMT (tandem mass tag)-based proteomic time course dataset
6 h 24 h 48 h 72 h RTi
unknown unknown unknown unknown unknown
(2). Navare et al., Virology, 2012

SUP-T1 cell line
FC-4hpi P-value FC-8hpi P-value FC-20hpi P-value Category
unknown unknown unknown unknown unknown unknown unknown
(3). Hyrcza et al., J. Virolo., 2007

Primary human CD4+ and CD8+ T Cells
Affymetrix Prob ID Fold Change In CD8? Category
204440_at 1.42 No downregulated in CD8+ cells

Protein Overview       top

Drug-protein Interaction       (annotations from DrugBank)      top

not found

Protein Secondary Structure       (annotations from PDB)      top

not found

HIV-1 Interaction       (annotations from NCBI HIV-1 Interaction Database)      top

HIV Partner Interaction Type PubMed
Envelope surface glycoprotein gp120 downregulates 17360657
Vpr downregulates 15611322
Nef downregulates 25275127
Tat upregulates 11751963
Vpu downregulates 25275127
Envelope surface glycoprotein gp120 upregulates 24162774
Nef upregulates 24204260
Pr55(Gag) downregulates 24505475
Envelope surface glycoprotein gp120 inhibits 19828628

Metabolic/Signalling Pathway       (annotations from KEGG database)      top

Pathway Accession Number Description
not found